![](/img/cover-not-exists.png)
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Becker, Pamela S., Alsina, Melissa, Zhong, Xiaobo, Hari, Parameswaran N., Rowley, Scott, Stadtmauer, Edward A., Vesole, David, Logan, Brent R., Weisdorf, Daniel J., Qazilbash, Muzaffar, Popplewell, LeVolume:
19
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2012.11.111
Date:
February, 2013
File:
PDF, 60 KB
english, 2013